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ABSTRACT
Partial least squares (PLS) and principle component regression (PCR) multivariate calibration methods were applied to the
simultaneous determination of carbidopa and levodopa using kinetic data from novel potentiometry methods. These methods were
based on the rate of chloride ion production in the reaction of carbidopa and levodopa with N-chlorosuccinimide (NCS) which was
monitored by a chloride ion-selective electrode. The experimental data shows suitability of ion-selective electrodes (ISEs) to be
used as detectors not only for the direct determination of chloride ion but also for simultaneous kinetic-potentiometric analysis using
chemometric methods. These methods are based on the differences observed in the production rate of chloride ions. The results
show that simultaneous determination of carbidopa and levodopa can be performed in their concentration ranges of 1.0 - 14.0 and 0.5
- 25.0 μg/mL, respectively. The total relative standard errors for applying PCR and PLS methods to 9 synthetic samples in the concentration range of 2.0 - 13.0 µg/mL for carbidopa and 1.0 - 18.0 µg/mL for levodopa were 4.81 and 4.29, respectively. The effects
of certain additives used as excipients upon the reaction rate were determined to assess selectivity of the method. Both methods
(PLS and PCR) were validated using a set of synthetic sample mixtures and then were successfully applied to the determination of
carbidopa and levodopa in several commercially available mixture formulations. The recoveries were satisfactory and comparable
to those obtained by applying the reference Pharmacopoeia method of high performance liquid chromatography.
Key words: simultaneous determination, kinetic-potentiometric, carbidopa, levodopa, PLS, PCR

INTRODUCTION
Levodopa [3-(3,4-dihydroxyphenyl)-L-alanine], an
important neurotransmitter has been used for the treatment of neural disorders such as Parkinson’s. Parkinson’s
disease is a progressive neurological disorder that occurs
when the brain fails to produce enough dopamine. This
drug is principally metabolized by an enzymatic reaction (dopa-decarboxilase) to dopamine compensating for
the deficiency of dopamine in the brain. Carbidopa has
been used as an inhibitor of the decarboxylase activity.
These drugs as a combination (levodopa-carbidopa) are
also used in ophthalmology for the treatment of tumors
and spasms and controlling poor muscle control caused
by CO and manganese intoxication(1-3). By administering
* Author for correspondence. Tel: +98-345-5226800;
Fax: +98-345-5233540; E-mail: m
 _karimi@pnu.ac.ir
ma.karimi43@gmail.com

levodopa combined with carbidopa, the concentration of
dopamine is controlled at an appropriate level effectively
with generally reduced side effects (4). In order to achieve
better curative effect and lower toxicity, it is very important to control the content of levodopa and carbidopa in
pharmaceutical tablets. From this perspective, considerable work has been done on their detection and quantification. Various methods such as, spectrophotometry(5),
spectrofluorimetry(6), gas chromatography(7), high performance liquid chromatography (HPLC)(8), radio immunoassay(9), chemiluminescence (10), potentiometry(11) and
voltammetric determination(12) have been reported in the
literature on the determination of these compounds in
various biological samples and pharmaceutical preparations. Many of these methods cannot be applied for the
simultaneous determination of these drugs and some
are expensive and require complex pretreatment or toxic
organic solvents. Damiani et al. designed and optimized
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a partial least squares (PLS) enhanced spectrophotometric method for the simultaneous determination of levodopa and carbidopa in pharmaceutical preparations, based
on their oxidation with potassium periodate (12). Madrakian et al. described two spectrophotometric methods
for the simultaneous determination of binary mixtures of
carbidopa and levodopa in pharmaceutical formulations,
by mean centering of ratio spectra and H-point standard
addition method (HPSAM)(13). The methods are based on
the difference in the absorption spectra for the products
of the reaction of carbidopa and levodopa with 4-aminobenzoic acid in the presence of periodate ion. Safavi et
al. also reported simultaneous kinetic spectrophotometric determination of these drugs by HPSAM(14). The
method was based on the difference in the rate of oxidation of these compounds with Cu(II)–neocuproine system
and formation of Cu(I)-neocuproine complex. Recently,
Chamsaz et al. reported a spectrophotometric method for
the simultaneous determination of ternary mixtures of
carbidopa, levodopa and methyldopa by multivariate calibration methods and artificial neural networks (ANN)(15).
The kinetic methodology was based on the difference of
reaction rates between oxidizing agent of tris (1,10-phenanthroline)-iron (III) complex (ferriin, [Fe(phen)3]3+) in
the presence of citrate and spectrophotometrically. All
the above mentioned chemometric methods (12-15) are
based on the spectrophotometrically determination and to
the best of our knowledge no one has reported any applications of the chemometric methods for the simultaneous
determination of these drugs based on the electrochemical methods. Thus, the usage of potentiometry technique
as a simple and inexpensive electroanalytical method is
highly interesting and important.
Electroanalytical techniques are excellent and
cheap procedures for the determination of trace chemical
species. In recent years the usage of chemometrics methods including principal component regression (PCR),
PLS, artificial neural network (ANN) and HPSAM in
electroanalytical chemistry has received considerable
attention for the extraction of more information from
experimental data as in other areas of analytical chemistry(16-18). In the field of potentiometry, several methods
have been reported based on flow injection system and
titration using PLS and ANN as modeling methods (1922)
. Recently, we reported the first application of PLS
and PCR multivariate calibration methods and HPSAM
to the simultaneous kinetic-potentiometric determination
of binary mixtures of hydrazine and its derivatives (23,24).
The methods were based on the differences observed
in the production rate of chloride ions in the reaction of
hydrazine and its derivatives with N-chlorosuccinimide
(NCS). The reaction rate of production of chloride ion
was monitored by a chloride ion-selective electrode.
This work reports the first application of PLS and
PCR multivariate calibration methods to the simultaneous
kinetic-potentiometric determination of binary mixture of
drugs using ion-selective electrodes (ISEs). These meth-

ods are based on the differences observed in the rate of
production of chloride ion in the reactions of NCS with
carbidopa and levodopa. The reaction rate of the production of chloride ion was monitored by a chloride ISE.

MATERIALS AND METHODS
Ι. Apparatus and Software
A solid-state chloride-selective electrode (Metrohm
Model 6.0502.120) was used in conjunction with a double
junction Ag/AgCl reference electrode (Metrohm Model
6.0726.100), whose outer compartment was filled with
a 10% (w/v) KNO3 solution. The Metrohm Model 780
potentiometer, attached to a Pentium (IV) computer, was
used for recording the kinetic potentiometric data. All
measurements were carried out in a thermostated (25
± 0.2°C), double-walled reaction cell with continuous
magnetic stirring. The electrode was stored in 1 × 10 -3
M potassium chloride solution when not in use. For pH
measurements, a Metrohm Model 780 pH meter with
a combination glass electrode was used. The data were
treated in an AMD 2000 XP (256 Mb RAM) microcomputer using MATLAB software. PLS and PCR analysis
were performed using PLS and PCR toolboxes in the
MATLAB 7.0 program.
A high-performance liquid chromatograph (Shimadzu, Japan) equipped with a Hypersi column (150 mm ×
3.9 mm i.d., 5 µm Japan), an UV detector and a recording
digital integrator (C-R6A, Shimadzu, Japan) were used.
The UV detector was set at 280 nm, and the recorder was
set at 1.0 cm/min.
ΙΙ. Reagents and Chemicals
All chemicals were of analytical reagent grade and
doubly distilled water was used throughout the experiment. Stock solutions (1000 μg/mL) of levodopa (Fluka)
and carbidopa (Fluka) were prepared in 100-mL flasks
by dissolving appropriate amounts in water and diluting
to the mark. Both solutions were stored in a refrigerator
at 4°C and protected from light. Under these conditions,
the solutions were stable for 15 days. A 0.05 M N-chlorosuccinimide stock solution was prepared by dissolving 0.6667g of NCS (Serva) in water and diluting to 100
mL. The solution was prepared daily and kept at 4°C
in an amber-coloured bottle in the dark. Acetate buffer
solution (0.05 M, pH 5.0) was prepared using acetic acid
and NaOH solutions and its pH was monitored with a pH
meter and adjusted as needed.
ΙIΙ. Procedure
Twenty five milliliters of doubly distilled water, 2.0
mL of buffer solution and 1.0 mL of 5 × 10 -2 M NCS solution were transferred into a thermostated (25ºC) reaction
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cell. Ten milliliters of the standard or sample solution of
levodopa, carbidopa or a mixture of them were injected
into the cell quickly, and after the stabilization of the
potential, all data were recorded. The potential changes versus time were recorded at the time intervals of 1s.
Simultaneous determination of levodopa and carbidopa
was performed by recording the potential changes for
each solution from 10 to 300 s. After each run, the cell
was emptied and washed twice with distilled water.
Using the standard analyte solutions, a calibration graph of (10∆E/S -1) versus concentration (fixed-time
method) was constructed (25) (Table 1), where ∆E is the
potential change in a selected time interval ∆t (usually 290 s) and S is the slope of the chloride electrode
response, which was determined periodically by successive additions of micro-amounts of 100 µL of 1.0 × 10 -2
- 3.0 M KCl standard solutions in 25.0 mL of water mixed
with 2.0 mL of buffer solution. The simultaneous determination of carbidopa and levodopa can be performed in
the concentration ranges of 1.0 - 14.0 and 0.5 - 25.0 μg/
mL, respectively.
PLS and PCR algorithms and their general principles
are similar. PLS and PCR have been used in this study to
resolve simultaneously mixtures of levodopa and carbidopa
by recording the potential for each solution from 10 to 300
s. In this research, a synthetic set of 33 solutions including
different concentrations of levodopa and carbidopa was
prepared. A collection of 24 solutions were selected as
the calibration set (Table 2) and the other 9 solutions were
used as the prediction set (Table 3). Their composition was
randomly designed to obtain more information from the
calibration procedure. Changes in the potential of the solutions were recorded between 10 and 300 s, which implies
experimental points (at 1- second intervals) were selected
for analysis. In this potential region, the maximum difference in kinetic behavior is shown. Kinetic-potentiometric data were collected in the Excel program and fed into
the MATLAB program. Data were mean-centered before
being input to the appropriate algorithms.
For the analysis of real samples, twenty tablets of
each sample containing levodopa and carbidopa were
accurately weighted and their solutions were prepared
through dissolving a certain amount of grounded tablets
in the weak acidic solutions and filtering the solutions.
The prepared solutions containing aliquot amounts of
levodopa and carbidopa were analyzed (n = 4).
For the HPLC experiments, the above stock solutions
of levodopa and carbidopa were employed. The mobile
phase and buffer were prepared based on the reference
method of US Pharmacopeia (26).

ments were conducted to establish the optimum conditions to achieve maximum sensitivities. In the proposed
analytical method, using suitable reagent to react with
levodopa and carbidopa under different rates as the first
step is very important. Under this condition, the rate
of halide ion production through the reaction of reagent
with levodopa and carbidopa will differ; and consequently the potentiometric responses for levodopa and for
carbidopa will be different. Various reactants such as 1fluoro-2,4-dinitrobenzene (FDNB), 1-chloro-2,4-dinitrobenzene (CDNB), 1-bromo-2,4-dinitrobenzene (BDNB),
N-bromosuccinimide (NBS), sodium dichloroisocyanurate (SDCC) and NCS were investigated as reagents for
reaction with levodopa and carbidopa to produce halide
ions. Preliminary studies showed that NCS is a suitable
reagent for our purpose. By using this reagent, we realized that the linear range and differences of reaction rate
for both species (levodopa and carbidopa) were better
than those for any other reagents.
NCS, a chlorinating and oxidizing agent is more
stable than alkali hypochlorite which contains chlorine
in the same oxidation state but disproportionates easily
to chlorate and chloride ions (27). In oxidation reactions,
NCS undergoes a two electron reduction to succinimide (NHS) and chloride ion. Alternatively, NCS may
be regarded as a source for hypochlorous acid, which is
generated by hydrolysis (Scheme 1):
Hypochlorous acid is probably responsible for the
oxidizing properties of NCS. Levodopa and carbidopa
are oxidized by NCS to ketonic and azoic derivatives,
respectively. Moreover, NCS is reduced to NHS (Scheme
2)(24-31):
All experimental parameters affecting the reaction rate of NCS with levodopa and carbidopa (electrode
characteristics, concentration of NCS, pH, etc) were optimized by “one at a time” studies.
I. Study of Electrode Characteristics
Characteristics of the chloride-selective electrode
in the acetate buffer were studied. Typical calibration
graphs for the chloride-selective electrode showed a linear
response in the range of 3 × 10 -6 - 1 M chloride. The slope
was found to be 56.4 mV/decade and remained almost
constant at 0.4 mV over 10 months of use in this system.
II. Effect of NCS Concentration and pH
The effect of NCS concentration on the reaction
O

O

RESULTS AND DISCUSSION
In order to accomplish simultaneous kinetic potentiometric determination of levodopa and carbidopa to be
implemented through PLS and PCR, a series of experi-
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The effect of each three types of surfactants (anionic, cationic and nonionic) and their concentrations on the
reaction rates of levodopa and carbidopa with NCS were
investigated. The results showed that each type of surfactants of sodium dodecyle sulfate (SDS), cetyltrimethyl
ammonium bromide (CTAB) and Triton X-100 (TX-100)
reduces the reaction rate of both species (levodopa and
carbidopa). Therefore, the reaction should be performed
without surfactants.
IV. Potential-times Behavior
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Figure 1. Potential-time curves for the reaction of NCS with 5 μg/mL
of levodopa (a), 15 μg/mL of carbidopa (b) and mixture of them (c).
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initial reaction but reaction of levodopa is completed in
300 s. This difference in the reaction rates allowed us to
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rate of levodopa and carbidopa and mixture of them was
investigated. The reaction rates of both species increase
with the concentration of oxidant (NCS) in the range of 5
× 10 -5 - 5 × 10 -2 M. Further increase in oxidizing agent
concentration was avoided due to the limited solubility
of NCS in water. Therefore, a concentration of 5 × 10 -2
M NCS was selected as the optimum concentration for
further studies.
The effect of pH on the reaction rates of levodopa
and carbidopa with NCS over the pH range of 2.0 to 9.0
was examined. Since, maximum differences in kinetic
behavior levodopa and carbidopa were observed at pH
5.0; this pH was selected as the optimum pH for both
analytes.
The electrode potential was also investigated at
different pHs. The electrode potential is stable in pure
NCS solutions. Therefore, NCS solutions behave like
dilute chloride solutions. The concentration of chloride,
equivalent to NCS (having the same potential), increases
with pH, and provides a constant background response
before injection of the sample solutions. Concentration
of chloride was minimized at pH 5.0.

7.0
10.0
15.0

Figure 1 shows the potential-time behavior of reactions of NCS with levodopa and carbidopa and mixtures
of them at the optimized conditions. Figure 2 shows typical reaction curves for the reaction of NCS with levodopa and carbidopa at different concentrations. As shown
Figures 1 and 2, the reaction of carbidopa was faster
than levodopa and was almost completed in 40 s after the

20.0

5mV
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Figure 2. Typical potential-time curves for the reaction of NCS with
levodopa (a) and carbidopa (b) at different concentrations (μg/mL).
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Table 1. Characteristics of calibration graphs for the determination of levodopa and carbidopa

a

Species

Linear range
(μg/mL)

Slope (μg/mL)

Intercept

Correlation coefficient
(n = 10)

Detection limita
(μg/mL)

Levodopa

1.0-14.0

0. 430

0.0706

0.9982

0.70

Carbidopa

0.5-25.0

0.752

-0.0306

0.9981

0.20

concentration corresponding to a net analytical signal equal to three times the standard deviation of the blank.

800

Table 2. Calibration set for constructing PLS and PCR method in
determination of levodopa and carbidopa (μg/mL)

600

Levodopa

Carbidopa

1

2.0

1.0

2

2.0

3.0

3

2.0

5.0

4

2.0

10.0

5

5.0

1.0

6

5.0

7.0

7

5.0

10.0

8

5.0

15.0

9

7.0

3.0

design the PLS and PCR methods for simultaneous determination of levodopa and carbidopa.
Under the optimum conditions, the amount of
(10∆E/S -1) of the produced at the reaction of NCS with
levodopa and carbidopa is linear with their concentrations (Figure 3). Characteristics of calibration graphs
for determination of levodopa and carbidopa are given in
Table 1.

10

7.0

5.0

11

7.0

7.0

12

7.0

18.0

13

9.0

5.0

14

9.0

7.0

PRESS

Sample number

400
200
0

0

2

4

6

8

10

12

Number of factor

Figure 3. Plot of PRESS against the numbers of factors for mixture
of levodopa and carbidopa for PCR (▲) and PLS (■).

15

9.0

10.0

16

9.0

15.0

17

11.0

7.0

V. Multivariate Calibration and Statistical Parameters

18

11.0

10.0

19

11.0

15.0

Multivariate calibration consists of establishment of
a relationship between matrices of chemical data. These
methods are based on a first calibration step in which a
mathematical model is built using a chemical data set
(e.g., potential values) and a concentration matrix data
set. The calibration is followed by a prediction set in
which this model is used to estimate unknown concentrations of a mixture from kinetic profile. Multivariate calibration methods are being successfully applied
to the multi-component kinetic determination to overcome some of the drawbacks of classical methods. Soft
algorithms such as PCR, PLS and ANN, which avoid
colinearity problems, have been used for simultaneous
determination of the analytes having the same chemical
properties that cannot be resolved with common methods.
The theories and applications of chemometric methods
such as PLS and PCR to the analysis of multi-component
mixtures have been discussed by several workers (32-35).
These multivariate calibration methods pave the way
to deal with the problem of ill conditioned matrices. In
particular, PCR and PLS techniques are called “factor
methods” because transform the high number of origi-

20

11.0

18.0

21

13.0

1.0

22

13.0

3.0

23

13.0

5.0

24

13.0

1.0

nal variables in to a smaller number of orthogonal variables called “factors” or “principal components”, which
are linear. PLS regression and PCR are methods used for
building regression models based on the latent variable
decomposition and set a relationship between the two
blocks, matrices X and Y, containing the independent, x,
and dependent, y, variables, respectively. These matrices
can be simultaneously decomposed into a sum of latent
variables, as follows:
X = TPT + E

(1)

Y = UQT + F

(2)
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Table 3. Prediction set for constructing PLS and PCR method in determination of levodopa and carbidopa

Sample

Predicted (μg/mL)

Actual (μg/mL)

PCR

Recovery (%)
PLS

PLS

PCR

Levodopa

Carbidopa

Levodopa

Carbidopa

Levodopa

Carbidopa

Levodopa

Carbidopa

Levodopa

Carbidopa

1

2.0

7.0

2.12

7.12

2.05

7.03

106.0

101.7

102.5

100.4

2

2.0

15.0

2.12

15.78

2.18

15.80

106.0

105.2

3

5.0

3.0

5.22

3.23

5.13

3.13

104.4

107.6

102.6

104.3

4

5.0

5.0

5.19

5.13

5.08

5.07

103.8

102.6

101.6

101.4

5

7.0

1.0

7.25

0.98

7.12

0.94

103.5

98.0

101.7

94.0

6

7.0

10.0

7.18

9.63

7.10

9.65

102.5

96.5

101.4

96.5

7

9.0

18.0

9.41

18.84

9.36

18.80

104.5

104.6

104.0

104.4

8

11.0

3.0

11.39

3.09

11.38

3.15

103.5

103.0

103.4

105.0

9

13.0

7.0

13.80

6.76

13.67

6.87

106.1

96.5

105.1

98.1

Mean
Recovery (%)

104.4

101.7

102.9

101.0

RSEP (%)

4.94

4.22

4.71

4.33

RSEPt (%)

4.81

in which T and U are the score matrices for X and
Y, respectively; P and Q are the loading matrices for X
and Y, respectively; E and F are the residual matrices. In
this procedure, it is necessary to find the best number of
latent variables for both methods (PLS and PCR), which
normally is performed by using cross-validation based on
the determination of minimum prediction error. The first
step in the simultaneous determination of species through
these methodologies involves constructing the calibration matrix for the binary mixture of levodopa and carbidopa. To construct the calibration set, we applied random
design to five levels to extract a great deal of quantitative
information using only a few experimental trials.
To select the number of factors (latent variables) in
the PLS and PCR algorithm a cross-validation without
one-sample methods was employed (32). An important
chemometric tool is called cross-validation. The basis
of the method is that the predictive ability of a model
formed on part of a dataset can be tested out by how
well it predicts the remainder of the data. It is possible
to determine a model using i-1 samples leaving out one
sample (i).
The optimum number of factors (latent variables) to
be included in the calibration model was determined by
computing the prediction error sum of squares (PRESS)
for cross-validated models using a high number of factors
(half the number of total standard + 1), which is defined
as follows:
¥
¦
PRESS  ¤ ¦
Ci
i 1 ¦
§
m

´
µ
Ci µµ
¶

2

(3)

where m is the total number of calibration samples,

104.0

105.3

4.29

Ĉi represents the estimated concentration, and Ci is the
reference concentration for the ith sample left out of
the calibration during cross validation. One reasonable
choice for the optimum number of factor would be the
number which yields the minimum PRESS. Since there
are a finite number of samples in the training set, in many
cases the minimum PRESS value causes over fitting for
unknown samples that were not included in the model. In
order to find the fewest number of factors, the F-statistic was used to carry out the significant determination (32).
Figure 3 shows a plot of PRESS against the factors
involved in the mixture of components. The optimum
number of factors for two components was 3 for both PLS
and PCR.
For the evaluation of the predictive ability of a multivariate calibration model, the root mean square error of
prediction (RMSEP) and the relative standard error of
prediction (RSEP) can be used (32) :
2
´
¥ N ¥
´
RMSEP  ¦ ¤ ¦ C i Ci µ / n µ
µ
¦ i 1 §
¶
§
¶

1

2

2
¥ N ¥ 
´ N
RSEP (%)  ¦ ¤ ¦ C i C i µ / ¤ C i
¦ i 1 §
¶ i 1
§

(4)

2

´
µ
µ
¶

1

2

s 100

(5)

where Ĉi represents the estimated concentration, Ci
and n are the actual analyte concentration and the number
of samples, respectively.
The squares of correlation coefficient (R 2), which is
an indication of the quality fit of all the data to a straight
line is presented by:

45
Journal of Food and Drug Analysis, Vol. 16, No. 5, 2008

2

N
2
¥
´ N
R 2  ¤ ¦ Ci C a µ / ¤ Ci C a
¶ j 1
i 1 §
(6)
Table 4 shows values of RSEP, RMSEP and R 2 for
each component using PLS and PCR. It is shown that the
obtained values for the statistical parameters are almost
the same for both PLS and PCR methods.

VI. Interference Studies
In order to assess the possible analytical applications
of the proposed methods, the effects of common excipients used in pharmaceutical preparations were studied.
Potential changes of a solution containing levodopa (2.0
μg/mL) and carbidopa (2.0 μg/mL) were analyzed for
four times. Afterwards the effect of interfering species at
different concentrations on the potential of this solution
was studied. A species was considered an interference
when its presence produced a variation in the concentration of the levodopa and carbidopa mixture (in the
period of 300 s) with more than 5% relative error. The
following excipients did not interfere in the maximum
tested concentrations (μg/mL) shown in parentheses:
starch (1000), sugar (500), galactose (500), glucose (500),
sucrose (500), riboflavin (100). Some other compounds
with significant redox properties (e.g., ascorbic acid) may
interfere in the proposed procedure. But our goal was the
determination of levodopa and carbidopa in tablets. In
these tablets, other redox compounds are absent.
VII. Application
The proposed methods were applied to determine simultaneously levodopa and carbidopa in several
commercially available pharmaceutical formulations.
Twenty tablets of each sample were accurately weighed
and their solutions were prepared by dissolving them
in water and filtering the solutions. The prepared solutions containing aliquot amounts of levodopa and carbidopa were analyzed (n = 4). The accuracy of proposed
methods was determined by analyzing the recoveries of
known amounts of analytes into samples and comparing test results from the proposed methods (PCR and
PLS) with those obtained applying the reference method
proposed in the based on HPLC. The reference method
was conducted using UV monitoring at 280 nm and
Hypersi column (150 mm × 3.9 mm i.d. 5 µm Japan).

A mixture of 11.04 g of monobasic sodium phosphate,
1.3 mL of sodium 1-decanesulfonate solution (0.24 g of
sodium 1-decanesulfonate dissolved in 1 liter of water)
and 950 mL of water in a beaker was prepared. The
flow rate, about 2 mL per minute, was adjusted until the
retention times for levodopa and carbidopa were 4 and 11
minutes, respectively. For sample preparation, 50 mg of
levodopa was transferred to a 100-mL volumetric flask.
An accurately weighed quantity of carbidopa, which is in
a ratio with levodopa that corresponds with the ratio of
carbidopa to levodopa in the tablets, was added. 10 mL
of 0.1M phosphoric acid was added warmed gently to
dissolve the standard mixed and then diluted with water
to the mark. Chromatograph five replicate injections of
the standard preparation, and recorded the peak response
as directed for procedure. The relative standard deviation was not more than 2.5% and the resolution factor
between levodopa and carbidopa was not less than 7. For
assay preparation, twenty tablets were weighed and finely
powdered. An accurately weighed portion of the powder,
equivalent to about 50 mg of levodopa, was transferred
to a 10-mL volumetric flask. Then 10 mL of 0.1 M phosphoric acid was added and mixed and then diluted with
water to the mark.
The quantitative results of this analysis are summarized in Table 5. Good agreements between results
obtained and the nominal values labeled and reference method indicate that PCR and PLS can be applied
successfully for simultaneous determination of levodopa and carbidopa in pharmaceutical samples. Although
commercial samples always contain excipients, good
recoveries confirmed that they do not seriously interfere
under the present conditions. A comparison of PLS and
PCR results with those provided by HPLC using standard t-test statistics revealed no significant differences
between the chemometrics-assisted methodologies and
the reference technique (Table 5).

CONCLUSIONS
This work as the first application of chemometrics
methods to the simultaneous determination of binary
mixture of levodopa and carbidopa shows the ability and
excellent performance of ISEs as detectors not only for
individually determination of produced or consumed
ions, but also in simultaneous kinetic-potentiomet-

Table 4. Statistical parameters calculated for the prediction set using PLS and PCR methods
Component

RSEP (%)

R2

RMSEP

PCR

PLS

PCR

PLS

PCR

PLS

Levodopa

4.33

4.22

0.4570

0.4192

0.9786

0.9988

Carbidopa

4.71

4.94

0.3997

0.3362

0.9916

0.9989
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Table 5. Simultaneous kinetic-potentiometric determination of levodopa and carbidopa in pharmaceutical samples using PCR and PLS
methods and comparison with HPLC(26).
Sample

Levodopa (mg)

Carbidopa (mg)

PCR

PLS

HPLC

td

td

PCR

PLS

HPLC

1a

105.7 (± 1.2)c

104.7 (± 1.1)c

104.3 (± 2.6)c

1.0

0.3

9.4 (± 0.6)c

9.8 (± 0.6)c

10.3 (± 2.4)c

b

c

c

c

2

257.4 (± 1.2)

256.8 (± 1.3)

262.8 (± 1.8)

1.9

1.5

c

24.4 (± 0.7)

c

24.6 (± 1.0)

c

25.5 (± 2.1)

td

td

0.8

0.4

1.0

0.9

a

(Levodopa,100 mg; Carbidopa,10 mg per tablet); Ramofarmin Co. IRAN
(Levodopa, 250 mg; Carbidopa, 25 mg per tablet); Alborz Daruo Co. IRAN
c
Standard deviation (s) is in parenthesis. The results are averages of four replicates and are given in mg per sample.
d
Calculated values of the statistical t coefficient for the PCR and PLS methods comparison with HPLC. The critical value at 95%
confidence level and 6 d.f. is t (ν = 6, 95%) = 2.45.
b

ric analysis. In addition, the abilities and advantages
of chemometrics methods such as PLS and PCR in the
analysis of multi-component mixtures and advantages
of ion-selective electrodes i.e. high selectivity, sensitivity and freedom from optical interferences along with the
selectivity, sensitivity, rapidity, flexibility and simplicity
of kinetic methods, produce very attractive and versatile techniques. Reproducibility and accuracy tests were
successful, and the recovery results were statistically
comparable to those obtained by the reference method
based on HPLC. The proposed methods are cheaper than
chromatographic separation methods. Furthermore, we
don’t need to use complex pretreatment or toxic organic
solvents in these methods. In other words, they belong to
green chemistry.
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